You can find original article here Nrn. Subscribe to our free daily Nrn newsletters. Doherty Enterprises Inc., one of the country’s largest franchisees, is adding Qdoba Mexican Eats to its portfolio with a new agreement to develop 27 restaurants in select New York and New Jersey markets throughout the next several years.  The agreement represents a strategic expansion for Doherty Enterprises, whose portfolio currently includes 158 restaurants across Applebee’s, Panera Bread, Wendy’s, Chevys Fresh M ...

Aspo Plc ANNOUNCEMENT 17.12.2025 Aspo Plc: Share repurchase 17.12.2025 In the Helsinki Stock Exchange Trade date 17.12.2025 Bourse trade Buy Share ASPO Amount 1 039SharesAverage price/ share 6,6608EURTotal cost 6 920,57EUR Aspo Plc now holds a ...

RICHMOND, Va., Dec. 17, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq: INDV) today announced results from a randomized, double-blind clinical trial published in JAMA Network Open. The study found that both the 100-mg and 300-mg monthly maintenance doses of SUBLOCADE® (extended- release buprenorphine) rapidly reduced opioid use and improved opioid abstinence and were well tolerated, with no new safety signals in individuals with moderate-to-severe opioid use disorder (OUD). Participants across both dose groups e ...

Time now for Options Corner. Joining us to take a deeper look at the chart is Rick Dukat, lead a market technician. All right, so Amazon's been the underperformer within the Mag 7.What trends do you notice. >> Yes, exactly. I mean, they now has the dubious distinction of being the Mag 7's worst performer year to date.Uh Google, Tesla, and Vidia are the top three, by the way. But Amazon only up about 1% versus the S&P up almost 16% on the year and the Mag 7 group up about 19% or so. When we also look at uh A ...

At the Institute of Influencer and Analyst Relations (IIAR>) Awards 2025, Omdia was named IIAR> Analyst Firm of the Year - 2025, breaking IDC's five-year winning streak. This recognition, awarded by the Analyst Relations (AR) community, underscores Omdia's unparalleled ability to deliver actionable insights and foster meaningful partnerships. Additionally, Alex Viscusi, Account Director, Informa TechTarget, was named IIAR> Analyst Client Partner of the Year Americas - 2025, reflecting her exceptional dedica ...

Wall Street is optimistic heading into year-end, but earnings updates are sounding more cautious. ...

Joining us now to discuss is Oaklo CEO Jacob Dwit. So you got to explain this to us, Jake. We hear plutonium from the Cold War and wonder is that a good thing.Is that safe. >> It's great. That's one of the things we demonstrated and showed is you can do it very safely.Um what's really important about it is this is a huge opportunity to fuel reactors basically to build them sooner and faster. Um, one of the big challenges I think as we've looked down the path over the next few years about how quickly we can ...

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Two Harbors Investment Corp. (NYSE: TWO) to UWM Holdings Corporation for 2.3328 shares of UWM Class A Common Stock for each share of Two Harbors common stock is fair to Two Harbors shareholders. Halper Sadeh encourages Two Harbors shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersade. ...

Cannabis stocks rallied Wednesday morning following fresh reports that President Donald Trump is poised to sign an executive order rescheduling marijuana from Schedule I to Schedule III. CGC stock is climbing. See the chart and price action here. The news sent a wave of optimism through the cannabis sector as investors anticipated long-awaited financial liberation associated with Schedule III: the removal of IRS Section 280E. Read Next: Elon Musk Prepares SpaceX IPO Valued At More Than RTX, Boeing, Lockheed ...

On track for initial clinical data in mid-2026Marks a pivotal step toward scalable, accessible, off-the-shelf cell therapies for solid tumours Oslo, Norway, 17 December 2025 – Zelluna (OSE: ZLNA), a company pioneering allogeneic off-the-shelf cell therapies for cancer, today announced the submission of its Clinical Trial Application (CTA) to the UK Medicines and Healthcare products Regulatory Agency (MHRA) for ZI-MA4-1, the Company’s lead candidate. The CTA submission marks Zelluna’s transition from preclin ...